Authors examined tumors from 1007 NSCLC patients for detection of KRAS, EGFR, ALK, HER2, BRAF, PIK3CA, MET, NRAS, MEK1, and AKT1 genes abnormalities. This evidence concerns the gene NRAS and non-small cell lung carcinoma.